Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Revenue (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Revenue data on record, last reported at $13.2 million in Q4 2025.

  • For Q4 2025, Revenue rose 59.85% year-over-year to $13.2 million; the TTM value through Dec 2025 reached $45.2 million, up 53.41%, while the annual FY2025 figure was $45.2 million, 53.41% up from the prior year.
  • Revenue reached $13.2 million in Q4 2025 per TLSI's latest filing, up from $11.6 million in the prior quarter.
  • Across five years, Revenue topped out at $13.2 million in Q4 2025 and bottomed at $3.0 million in Q1 2023.
  • Average Revenue over 4 years is $7.4 million, with a median of $7.3 million recorded in 2024.
  • The widest YoY moves for Revenue: up 116.39% in 2024, down 41.52% in 2024.
  • A 4-year view of Revenue shows it stood at $3.2 million in 2022, then surged by 77.34% to $5.7 million in 2023, then soared by 44.4% to $8.3 million in 2024, then surged by 59.85% to $13.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $13.2 million in Q4 2025, $11.6 million in Q3 2025, and $11.2 million in Q2 2025.